Evaluation of Intranasal Naltrexone and Naloxone

NCT03851731 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Opioid-use Disorder

Interventions

DRUG: Naltrexone
DRUG: Naloxone
DRUG: Naltrexol

Sponsor

National Institute on Drug Abuse (NIDA)